Bimo Finandito

4 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNSFDIETSP3 refused lines

  Dietary ingredient without safety assurance

  The product appeared to be a dietary supplement or dietary ingredient for which there is inadequate information to provide reasonable assurance that it does not present a significant or unreasonable risk of illness or injury.

• LIST INGRE2 refused lines

  Ingredients not listed

  The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Bimo Finandito

Is Bimo Finandito on an FDA import alert?

No listing for Bimo Finandito appears in the FDA import alerts SupplierRadar checked on October 25, 2026. Country-wide alerts may still apply to its products; see the Indonesia page.

Has FDA refused shipments from Bimo Finandito?

Yes. FDA refused 4 shipment lines from Bimo Finandito between December 9, 2016 and January 5, 2018. The most recent, on January 5, 2018, was kratom (herbal and botanicals, not teas ii), charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Bimo Finandito's shipments?

The most frequent charges are UNSFDIETSP (dietary ingredient without safety assurance, 3 lines) and LIST INGRE (ingredients not listed, 2 lines).

What is Bimo Finandito's FEI number?

Bimo Finandito's FDA Establishment Identifier (FEI) is 3012683775.